Watchlist Price Alert

OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · Real-Time Price · USD

2.46

0.01 (0.41%)

At close: Jun 30, 2025, 1:39 PM

OKYO Pharma Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	826.85K	4.05M	2.7M	6.89M	234.96K	627.56K	n/a	n/a	5.13M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.86M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	580.94K	n/a	n/a	n/a	326.22K	111.36K	47.65	n/a	n/a
Inventory	n/a	n/a	-1.49K	34.00	-792.07	125.90	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	76.28K	263.09K	85.46K	n/a	n/a	113.79K
Total Current Assets	1.54M	5.2M	4.3M	6.99M	566.73K	758.75K	47.65	16.86M	5.37M
Property-Plant & Equipment	3.35K	7.22K	5.22K	104.64K	30.66K	1.1K	n/a	n/a	17.16M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.65M
Total Long-Term Assets	3.35K	7.22K	5.22K	104.64K	30.66K	1.1K	n/a	n/a	26.81M
Total Assets	1.54M	5.2M	4.3M	7.09M	597.4K	759.86K	n/a	n/a	32.18M
Account Payables	6.13M	1.02M	517.67K	210.99K	479.97K	381.76K	n/a	141.79K	124.12K
Deferred Revenue	n/a	n/a	n/a	n/a	-0.11	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	1.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	1.71M	323.06K	1.46M	21.58K	-1.13K	87.59K	n/a	16.95K
Total Current Liabilities	7.42M	7.26M	1.35M	1.71M	710.66K	426.72K	n/a	n/a	181.34K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	64.61K	26.54K	n/a	n/a	n/a	n/a
Total Liabilities	7.42M	7.26M	1.35M	1.77M	737.2K	426.72K	n/a	n/a	181.34K
Total Debt	n/a	2.22M	n/a	98.76K	31.62K	n/a	n/a	n/a	n/a
Common Stock	n/a	131.39M	123.98M	111.63M	n/a	89.22M	n/a	n/a	95.12M
Retained Earnings	-142.52M	-125.7M	-112.43M	-106M	-85.88M	-88.97M	n/a	n/a	-64.71M
Comprehensive Income	-11.31M	-11.45M	-11.01M	12.82M	2.22M	82.12K	n/a	n/a	-276.54K
Shareholders Equity	-5.88M	-2.05M	2.95M	5.32M	-139.8K	333.14K	n/a	n/a	32M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.86M	n/a